Seminars in Hematology
Volume 46, Issue 1 , Pages 1-2 , January 2009

Acute Lymphoblastic Leukemia: Introduction

References 

  1. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354:166–178
  2. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukemia. Lancet. 2008;371:1030–1043
  3. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med. 2004;350:1535–1548
  4. Fröhling S, Döhner H. Chromosomal abnormalities in cancer. N Engl J Med. 2008;359:722–734
  5. Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton D, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007;446:758–764
  6. Golub TR. Genomics: global views of leukaemia. Nature. 2007;446:739–740
  7. Pui CH, Jeha S. New therapeutics strategies for the treatment of acute lymphoblastic leukaemia. Nat Rev Drug Discov. 2007;6:149–165
  8. Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128:683–692
  9. Krivtsov AV, Armstrong SA. MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer. 2007;7:823–833
  10. Le Viseur C, Hotfilder M, Bomken S, Wilson K, Röttger S, Schrauder A, et al. In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. Cancer Cell. 2008;14:47–58
  11. Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. Nature. 2004;429:464–468
  12. Campana D. Status of minimal residual disease testing in childhood haematological malignances. Br J Haematol. 2008;Aug 15. [Epub ahead of print] PMID: 18710378

PII: S0037-1963(08)00169-8

doi: 10.1053/j.seminhematol.2008.09.011

Seminars in Hematology
Volume 46, Issue 1 , Pages 1-2 , January 2009

Article Tools